Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years

Authors: Iversen P.¹; Tyrrell C.J.; Kaisary A.V.; Anderson J.B.; Baert L.; Tammela T.; Chamberlain M.; Carroll K.; Gotting-Smith K.; Blackledge G.R.P.

Source: Urology, Volume 51, Number 3, March 1998 , pp. 389-396(8)

Publisher: Elsevier

Language: English

Document Type: Short communication

DOI: 10.1016/S0090-4295(98)00004-1

Affiliations: 1: aUniversity of Copenhagen, , Copenhagen, Denmark

Links for this article

http://www.ingentaconnect.com/els/00904295/1998/00000051/00000003/art00004
http://openurl.ingenta.com/content?genre=article&issn=0090-4295&volume=51&issue=3&spage=389&epage=396
http://dx.doi.org/10.1016/S0090-4295(98)00004-1